A groundbreaking weight loss invention could soon make it possible to drop those extra pounds without a single change in your diet.

Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

The cutting-edge nanoparticle system, engineered to deliver therapeutic molecules directly to the digestive tract, has shown significant potential to prevent diet-induced obesity.

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...